Close
Novotech
Jabsco PureFlo 21 Single Use

Thermo Fisher Scientific Completes Sales of Athena Diagnostics and Lancaster Laboratories

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Johnson & Johnson Wins DARZALEX Self-Administration EU Nod

Johnson & Johnson has received a key regulatory endorsement...

Transcend Acquisition Advances Otsuka Neuroplastogen Focus

Japanese pharmaceutical company Otsuka has moved to deepen its...

Novartis $2bn Excellergy Acquisition Boosts Allergy Pipeline

Novartis has entered into an agreement to acquire biotech...
- Advertisement -

Thermo Fisher Scientific Inc., the world leader in serving science, has completed the previously announced sales of its two laboratory-testing services businesses, Athena Diagnostics and Lancaster Laboratories, in two separate transactions, resulting in total proceeds of $940 million.

Athena Diagnostics has been sold to Quest Diagnostics for $740 million. Based in Worcester, Mass., Athena Diagnostics is a leading reference laboratory that provides comprehensive diagnostic testing for neurological and other diseases. The business had approximately $110 million in revenues for full year 2010, has approximately 300 employees and was part of Thermo Fisher’s specialty diagnostics business within its Analytical Technologies Segment.

 

Latest stories

Related stories

Johnson & Johnson Wins DARZALEX Self-Administration EU Nod

Johnson & Johnson has received a key regulatory endorsement...

Transcend Acquisition Advances Otsuka Neuroplastogen Focus

Japanese pharmaceutical company Otsuka has moved to deepen its...

Novartis $2bn Excellergy Acquisition Boosts Allergy Pipeline

Novartis has entered into an agreement to acquire biotech...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »